Cipla rises 2% as drugmaker launches remdesivir generic at Rs 4,000 per vial
Pharmaceutical major Mylan NV said its generic version of remdesivir
will be priced at Rs 4,800
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-rises-2-as-drugmaker-launches-remdesivir-generic-at-rs-4000-per-vial/articleshow/76868771.cms
will be priced at Rs 4,800
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-rises-2-as-drugmaker-launches-remdesivir-generic-at-rs-4000-per-vial/articleshow/76868771.cms
Comments
Post a Comment